Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579631 · ClinicalTrials.gov registry record
Adolescent Survivors of Cancer or Similar Illnesses
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 148
- Enrollment target
NCT00579631: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00579631 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 148 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00579631 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 148 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the health behaviors of young adults who have been treated for cancer, leukemia, or similar illnesses. We will also ask you some questions about your family members' and friends' health behaviors. We plan to use the findings from this study to design new programs to help teenage cancer survivors resist doing things that might harm their health.
Interventions
- BEHAVIORAL Questionnaire or Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2004-06-22 |
| Est. Completion | 2021-02-08 |
What the finished NCT00579631 record still lists
NCT00579631 is an observational study that tracks outcomes without assigning an intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire or Interview is the first listed.
NCT00579631 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00579631 about?
NCT00579631 is a clinical study titled "Adolescent Survivors of Cancer or Similar Illnesses". The purpose of this study is to examine the health behaviors of young adults who have been treated for cancer, leukemia, or similar illnesses. We will also ask you some questions about your family members' and friends' health behaviors. We plan to use the findings from this study to design new progr...
What is the current status of trial NCT00579631?
This trial is currently completed. The enrollment target is 148 participants. The study started on 2004-06-22. Estimated completion is 2021-02-08.
What interventions are being tested in trial NCT00579631?
The interventions under investigation include: Questionnaire or Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT00579631?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI